Breast Lesion Localization Market worth $305 million by 2026 - PowerPoint PPT Presentation

About This Presentation
Title:

Breast Lesion Localization Market worth $305 million by 2026

Description:

The breast lesion localization market is expected to reach USD 305 million by 2026 from USD 244 million in 2021, will grow at a CAGR of 4.6% during the forecast period. – PowerPoint PPT presentation

Number of Views:2
Slides: 6
Provided by: Prachi001
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Breast Lesion Localization Market worth $305 million by 2026


1
(No Transcript)
2


The breast lesion
localization market is expected to reach USD 305
million by 2026 from USD 244 million in 2021,
will grow at a CAGR of 4.6 during the forecast
period.
3
The growth of this market is mainly
attributed to the growing incidence of breast
cancer, the increasing rate of the geriatric
population (as age contributes to the risk of
breast cancer), the rising awareness on the early
detection of breast cancer in the coming years
and improved reimbursement scenario. However,
several factors, such as errors in screening
alongside misdiagnosis and uncertainty in
regulatory approval procedures are expected to
restrain the growth of the breast lesion
localization market during the forecast period.
4
Hologic is a leading player in the global
breast lesion localization methods market. The
broad portfolio of breast lesion localization
products is a major factor responsible for its
large share in this market. The company focuses
on both organic and inorganic growth strategies
to enhance its footprint in the global market.
Additionally, over the last few years, Hologic
has strengthened its customer base and expanded
its product portfolio through inorganic growth
strategies, such as acquisitions and
partnerships. With its strong product portfolio
and wide geographic presence, Hologic is expected
to witness significant growth in the breast
lesion localization market during the forecast
period.
5
Becton, Dickinson and Company (BD) is the
second leading player in the breast lesion
localization market. Through its Medication
Delivery Solutions segment, the company offers
wire and radio-guided localization devices in the
breast surgery market. The company has acquired a
product line of localization wires and devices to
enhance its presence in this market. The company
now focuses upon RD to introduce newer and
technologically sound products in the breast
lesion localization market. The company marks
footprints in various countries across the globe.
Write a Comment
User Comments (0)
About PowerShow.com